Topamax Caused Birth Defects, Lawsuits Allege

December 17, 2013

Important Information

ClassAction.org is no longer reviewing claims for this case. The information here is for reference only. Up-to-date information and resources can be found here.

Comments |

At A Glance

This Alert Affects:
Women who took Topamax (topiramate) while pregnant and delivered babies with birth defects.
Manufacturer:
Janssen Pharmaceuticals
Intended Use:
Topamax is prescribed to treat epilepsy and prevent migraine headaches. It is also used off label to treat other conditions including alcoholism, obesity, and bipolar disorder.
FDA Warning:
On March 4, 2011, the FDA issued a safety announcement for Topamax after data suggested that women who took the drug while pregnant faced an increased risk of delivering infants with oral clefts. The agency announced that the drug's classification would change to Pregnancy Category D, indicating that human studies have shown the drug can harm a fetus, and that its label would include a stronger warning about oral defects.
What Can I Collect?
Reimbursement for surgery, rehabilitation, and other medical expenses, as well as compensation for pain and suffering.
Type of Lawsuit:
Mass Tort